A new strategy for glycoprotein synthesis:: ligation of synthetic glycopeptides with truncated proteins expressed in E-coli as TEV protease cleavable fusion protein

We report here the use of TEV protease cleavable fusion proteins to produce glycosylated bioactive peptides and proteins. Bacterial expression was utilized to produce two fusion proteins, GPRT-C37-H6 and His-tagged interleukin-2 (amino acids 6-133). which when cleaved by the tobacco etch virus NIa protease (TEV protease) to generate HIV entry inhibitor peptide, C37-H6 and a truncated version of the cytokine interleukin-2, both containing N-terminal cysteines. The N-terminal cysteine containing C37-H6 and truncated interleukin-2 were then joined to a synthetic glycopeptide thioester utilizing native chemical ligation under nondenaturing and denaturing conditions, respectively. The ligations of the glycopeptide to the C37-H6 peptide and the truncated interleukin-2 protein both proceeded in high yield, though the size. and physical properties of the two polypeptides differ greatly. (C) 2004 Elsevier Ltd. All rights reserved.